Margaret Armstrong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Margaret Armstrong has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Daniel
The Hospital for Tropical Diseases, London, UK
1 shared publication - Anand S. Iyer
Division of Pulmonary, Allergy, and Critical Care Medicine University of Alabama at Birmingham Birmingham Alabama USA
1 shared publication - Annemarie Hennessy
Faculty of Medicine and Health, The University of Sydney
1 shared publication - Avery C. Bechthold
College of Nursing, University of Tennessee Knoxville, Knoxville, TN, USA
1 shared publication - Cynthia J. Brown
Department of Internal Medicine Louisiana State University School of Medicine New Orleans Louisiana USA
1 shared publication Diana Phillips
The Hospital for Tropical Diseases, London, UK
1 shared publication
Latest Publications
- 12 May 2026
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 72 (2) , 240-253
Serious Illness Care Exclusion, Disclosure, and Trust For Older Gay Men and Caregivers in the Deep South
- 12 May 2026
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 72 (2) , 240-253
Serious Illness Care Exclusion, Disclosure, and Trust For Older Gay Men and Caregivers in the Deep South
- 7 December 2022
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 65 (4) , 335-347.e3
Project EPIC (Early Palliative Care In COPD): A Formative and Summative Evaluation of the EPIC Telehealth Intervention
- 7 December 2022
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 65 (4) , 335-347.e3
Project EPIC (Early Palliative Care In COPD): A Formative and Summative Evaluation of the EPIC Telehealth Intervention
- 1 May 2016
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 23 (5) , taw050
Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers
Background: Few studies have investigated incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. The clinical presentations of these two diseases are often similar and difficult to distinguish. This study was conducted to investigate the incidence rate and the risk factors for symptomatic giardiasis and strongyloidiasis in returned tropical travellers. Methods: We retrospectively analysed 3306 consecutive attendances presenting to the emergency clinic at the Hospital for Tropical Diseases in London, the UK from September 2008 to May 2010. Odds ratios between the diagnoses and patient variables were analysed by logistic regression. Results: Giardiasis was diagnosed in 92/3306 cases (2.8%, proportionate morbidity), and the incidence rate per 1000 person-months was 12.5. Multivariate analysis with logistic regression revealed that Caucasian ethnicity (adjusted odds ratio (aOR): 2.37, 95% confidence interval (CI): 1.12–5.03, P value = 0.025), travel length ≥32 days (aOR: 2.63, 95%CI: 1.43–4.83, P = 0.002), travelling to South or South East Asia (aOR: 4.90, 95%CI: 2.03–11.8, P < 0.001, aOR: 3.36, 95%CI: 1.43–7.93, P = 0.006), afebrile presentation (aOR: 2.14, 95%CI: 1.14–4.03, P = 0.018), and presenting with gastro-intestinal symptoms (aOR: 14.6, 95%CI: 6.08–35.0, P < 0.001) were all associated with giardiasis. In contrast, strongyloidiasis was found only in 0.94% (proportionate morbidity) of the cases (31/3306), and the incidence rate per 1000 person-months was 3.1. Multivariate analysis revealed that male sex (aOR: 3.05, 95%CI: 1.36–6.85, P = 0.007), and non-Caucasian ethnicity (aOR: 2.69, 95%CI: 1.32–5.49, P = 0.007) were associated with strongyloidiasis. Conclusions: The incidence rate and risk factors for both infectious diseases were identified. The results of this study might guide clinicians to make more accurate and timely diagnoses in returned tropical travellers.
- 1 May 2016
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 23 (5) , taw050
Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers
Background: Few studies have investigated incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. The clinical presentations of these two diseases are often similar and difficult to distinguish. This study was conducted to investigate the incidence rate and the risk factors for symptomatic giardiasis and strongyloidiasis in returned tropical travellers. Methods: We retrospectively analysed 3306 consecutive attendances presenting to the emergency clinic at the Hospital for Tropical Diseases in London, the UK from September 2008 to May 2010. Odds ratios between the diagnoses and patient variables were analysed by logistic regression. Results: Giardiasis was diagnosed in 92/3306 cases (2.8%, proportionate morbidity), and the incidence rate per 1000 person-months was 12.5. Multivariate analysis with logistic regression revealed that Caucasian ethnicity (adjusted odds ratio (aOR): 2.37, 95% confidence interval (CI): 1.12–5.03, P value = 0.025), travel length ≥32 days (aOR: 2.63, 95%CI: 1.43–4.83, P = 0.002), travelling to South or South East Asia (aOR: 4.90, 95%CI: 2.03–11.8, P < 0.001, aOR: 3.36, 95%CI: 1.43–7.93, P = 0.006), afebrile presentation (aOR: 2.14, 95%CI: 1.14–4.03, P = 0.018), and presenting with gastro-intestinal symptoms (aOR: 14.6, 95%CI: 6.08–35.0, P < 0.001) were all associated with giardiasis. In contrast, strongyloidiasis was found only in 0.94% (proportionate morbidity) of the cases (31/3306), and the incidence rate per 1000 person-months was 3.1. Multivariate analysis revealed that male sex (aOR: 3.05, 95%CI: 1.36–6.85, P = 0.007), and non-Caucasian ethnicity (aOR: 2.69, 95%CI: 1.32–5.49, P = 0.007) were associated with strongyloidiasis. Conclusions: The incidence rate and risk factors for both infectious diseases were identified. The results of this study might guide clinicians to make more accurate and timely diagnoses in returned tropical travellers.
- Open Access
- 1 February 2006
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (2) , 107
Cytokine-induced in vivo expansion and mobilization of marrow mesenchymal stem cells in nonhuman primates
- 1 February 2006
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (2) , 107
Open AccessCytokine-induced in vivo expansion and mobilization of marrow mesenchymal stem cells in nonhuman primates